MPOD 3821 CHRONOLOGY

File: 120396_sep96_decls1_0009.txt
Page: 0009
Total Pages: 33

Subject: MPOD 3821 CHRONOLOGY                                            

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003202

Folder Title: CHRONOLOGY                                                                                      

Document Number:          1

Folder SEQ  #:         29









                                        SECRET
                  vaccine inventory analysis;

                  No change in threat; AX vaccine production has been
              maximized                  could be vaccinated by end May 91
              and         by end Dec 91); and that information on additiona
              AX and BT vaccine proudction would be due from the Tri-Service
              Task Force on 19 Nov 90.

          43. 5 Nov 90 - Question regarding shelf-life of AX vaccine posed
          to DDMR by DJS. Chairman apparently was asked this while at a
          social event. From COL Lewis: only a matter of FDA extending
          shelf life of various expired lots. Not anticipated to be a
          problem.

          44. 6 Nov 90 - Memo from ASD (Atomic Energy-Mr. Richardson,
          Deputy for Chemical Matters) sent to addressees (J5 and J4),
          "Biological Warfare Meeting" to be held on 9 November. Purpose
          was to provide basic BW data.

          45. 6 Nov 90 - Memorandum for Record (USAMRID/Dr. Linden)
          concerning "Phone Conversation with Dr. Bob Mikulak." Highlighted
          the possible ramifications, in the context of the provisions of
          the Biological Warfare Convention, of the Army undertaking the
          production of large numbers of doses of BT vaccine. Reaction was
          that production of such large quantities falls within permitted
          activities of the BWC.

          46. 9 Nov 90 - Meeting attended by J4 MRD representative.
          Proposed agenda included introduction, threat, medical effects of
          biological agents, dissemination, laydown patterns, downwind
          hazards. OSD group would continue to meet in order to develop a
          set of policy questions to provide direction to CIA so that all
          bases are covered.








          47. 9 Nov 90 - Trip to Michigan Department of Public Health Lab
          (Lansing, MI) by J5 (BG Jumper, COL Fleming) and J4 (ADM Smyth,
pose: Determine problems and prospects affecting
          production of BW vaccines. visited the Director of the Lab (Dr.
          George Anderson) and the Chief of Biologic Products Division (Dr.
          Robert Myers).

              -- Increases in AX vaccine production favorable. Follow-on
              estimates are for additional vaccine for
              late-March, yielding ability to protect



                                           9

                                                 UNCLASSIFIED

Document 33 f:/Week-36/BX003202/CHRONOLOGY/mpod 3821 chronology:1108961508372
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003202
Unit = OTSG
Parent Organization = HSC
Folder Title = CHRONOLOGY
Folder Seq # = 29
Subject = MPOD 3821 CHRONOLOGY
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 08-NOV-1996